Integra Lifesciences Holdings Corp
IART- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000917520
No open-market purchases or sales by Integra Lifesciences Holdings Corp insiders were filed in the last 90 days; 212 institutions reported holding it in 13F filings for Q2 2026, worth $1.32B in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Integra Lifesciences Holdings Corp as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 238
- −41 vs. Q1 2024
- Shares held
- 70.9M
- +5.01M (+7.6%) vs. Q1 2024
- Total value
- $2.07B
- −$271.4M (−11.6%) vs. Q1 2024
- New holders
- 36
- 100 more added
- Sold out
- 77
- 72 more reduced
2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IART on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 212 | $1.32B |
| Q1 2026 | 202 | $704.7M |
| Q4 2025 | 205 | $919.4M |
| Q3 2025 | 207 | $1.04B |
| Q2 2025 | 209 | $896.9M |
| Q1 2025 | 220 | $1.62B |
| Q4 2024 | 223 | $1.57B |
| Q3 2024 | 225 | $1.24B |
| Q2 2024 | 238 | $2.07B |
| Q1 2024 | 281 | $2.34B |
| Q4 2023 | 284 | $2.92B |
| Q3 2023 | 263 | $2.63B |
| Q2 2023 | 283 | $2.85B |
| Q1 2023 | 280 | $4.18B |
| Q4 2022 | 281 | $4.20B |
| Q3 2022 | 282 | $3.13B |
| Q2 2022 | 285 | $3.95B |
| Q1 2022 | 278 | $4.80B |
| Q4 2021 | 277 | $5.19B |
| Q3 2021 | 262 | $5.27B |
| Q2 2021 | 264 | $5.10B |
| Q1 2021 | 257 | $5.10B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Integra Lifesciences Holdings Corp; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −881−100.0% | Sold out |
| TD Private Client Wealth LLC | 0 | $0 | 0.00% | −559−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −534−100.0% | Sold out |
| Asset Dedication, LLC | 0 | $0 | 0.00% | −406−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −237−100.0% | Sold out |
| Ci Investments Inc. | 0 | $0 | 0.00% | −132−100.0% | Sold out |
| Prestige Wealth Management Group LLC | 0 | $0 | 0.00% | −87−100.0% | Sold out |
| Park Place Capital Corp | 0 | $0 | 0.00% | −87−100.0% | Sold out |
| CIBC Private Wealth Group, LLC | 0 | $0 | 0.00% | −56−100.0% | Sold out |
| Elequin Capital LP | 0 | $0 | 0.00% | −43−100.0% | Sold out |
| Eagle Bay Advisors LLC | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| Venturi Wealth Management, LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Bell Investment Advisors, Inc | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |
| Cipher Capital LP | – | – | – | – | Not filed |